SOURCE: Hansen Medical Inc.

March 12, 2008 09:00 ET

Hansen Medical Receives 2008 Frost & Sullivan Award for Product Innovation

MOUNTAIN VIEW, CA--(Marketwire - March 12, 2008) - Hansen Medical, Inc. (NASDAQ: HNSN), a developer of new generation robotic technology for accurate and stable control of catheter movement in 3D during cardiac procedures, announced today that it has received the Frost & Sullivan 2008 Product Innovation Award in the field of U.S. Image-Guided and Robotic-Assisted Surgery Devices. Frost & Sullivan will present the award to Gary C. Restani, president and chief operating officer of Hansen Medical at the 2008 Excellence in Medical Technologies & Life Sciences Awards Banquet, today at the Hyatt Fisherman's Wharf in San Francisco.

"Hansen Medical has demonstrated excellence in the development and commercialization of its innovative Sensei™ Robotic Catheter System and Artisan™ Control Catheter," said Venkat Rajan, Medical Devices Industry Manager with Frost & Sullivan. "The system allows physicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during the diagnostic phase of complex cardiac arrhythmia treatment."

To identify an award recipient, Frost & Sullivan's analyst team tracks all new product launches, R&D spending, products in development and new product features and modifications. All new product launches and new products in development in each company are compared and evaluated based on the degree of innovation and customer satisfaction. Frost & Sullivan then presents the award to the company ranked number one in overall product success in each award category.

In addition to the methodology described above, there are specific criteria used to determine the final selection. Hansen Medical was also judged by Frost & Sullivan to have excelled in the following criteria:

--  Significance of new product in its industry
--  Competitive advantage of new product in its industry
--  Product innovation in terms of unique or revolutionary technology
--  Number of competitors with similar products

"We are honored to receive this prestigious award from Frost & Sullivan in recognition of the contributions we are already making in electrophysiology procedures," said Restani. "This award recognizes the important role that Hansen Medical's technological innovation plays in advancing patient treatment options, and we intend to leverage this innovation to contribute to vascular and structural heart applications in the future."

About Hansen Medical, Inc.

Hansen Medical, founded in 2002 and based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei Robotic Catheter system, is cleared by the FDA for manipulation and control of certain mapping catheters in electrophysiology procedures. The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation, have not been established. Additional information can be found at

About Frost & Sullivan

Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit

Forward-Looking Statements

This press release contains forward-looking statements regarding, among other things, statements relating to goals, plans, beliefs, expectations, objectives and future events. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Examples of such statements include statements about plans for integrating technologies, beliefs about the future benefits of new products, expectations about the possible results from the use of new products and intentions to expand into new applications. These statements are based on the current estimates and assumptions of our management as of the date of this press release and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that may cause actual results to differ materially from those indicated by forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others, the risks and uncertainties inherent in our business related to; potential safety and regulatory issues; the scope of potential use of current and future products; competition from other companies; and our ability to successfully market and support our products. These and other risks are described in greater detail under the heading "Risk Factors" contained in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2007 filed with the Securities and Exchange Commission (SEC) on February 28, 2008 and the risks discussed in our other filings with the SEC. Given these uncertainties, you should not place undue reliance on these forward-looking statements. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available.

"Hansen Medical," "Sensei," "Artisan," "Hansen Artisan," as well as the Hansen Medical "heart design" are trademarks of Hansen Medical, Inc.

Contact Information